跳至主要内容
临床试验/CTRI/2020/07/026404
CTRI/2020/07/026404已完成未知

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease - A Pilot Study

Institute of Liver and Biliary Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) CLD with grade III ascites with Na less than 130, Systolic BP less than 90 and type 2 HRS.
  • 2) ACLF (APASL criteria) with Na less than 130, Systolic BP less than 90 and AKI.

排除标准

  • 1) age < 18 and > 75,
  • 2) Pregnancy,
  • 3) Splanchnic venous thrombosis,
  • 4) Hepatocellular Carcinoma,
  • 5) Hepaticencephalopathy,
  • 6) Significant cardiopulmonary disease,
  • 7) Uncontrolled diabetes,
  • 8) Hypertension,
  • 9) Intrinsic renal disease,
  • 10) Peripheral vascular disease.

研究者

相似试验